English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background One of the advantages of CT angiography (CTA) over MRA for transcatheter aortic valve replacement (TAVR) planning is the ability to display aortic valve and arterial calcification accurately. However, in many patients who are TAVR candidates, renal impairment makes iodinated contrast media undesirable or contraindicated. Further, in patients with severe renal impairment, gadolinium based contrast agents may be problematic because of the perceived risk of NSF. We hypothesized that in patients where ferumoxytol-enhanced MRA (FEMRA) is a suitable alternative to CTA, vascular and valvular calcification may be accurately displayed over luminal anatomy by fusing non-contrast CT and FEMRA in these patients. Methods Nine patients who underwent FEMRA for assessment of arterial access anatomy prior to TAVR had additional non-contrast CT of the thorax and abdomen. CT and MR DICOM data were processed in a commercially available software (Mimics V17.0, Materialize) and the calcium from the CT was isolated and registered to the FEMRA data.

Ferumoxytol MRA and non-contrast CT fusion in TAVR candidates with renal failure